Press Release
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Metropolis Healthcare reported robust Q4FY26 results with revenue of INR 425 Cr, up 23% YoY. EBITDA jumped 71% to INR 108 Cr with margin expanding to 25.4% from 18.5% a year ago. PAT rose 75% to INR 51 Cr, reflecting strong operational efficiency and cost controls. The company crossed the 5,000+ centres milestone and saw patient volumes grow 11% YoY and test volumes increase 14% YoY. B2C revenues grew 20% YoY while B2B revenues increased 28% YoY, driven by rising preventive healthcare adoption and stronger doctor relationships. The Board also approved a dividend of ₹1 per share.
The strong margin expansion and double-digit revenue growth indicate improving operational leverage and market share gains. The dividend declaration provides additional shareholder returns. These results suggest healthy underlying demand for diagnostics services and efficient cost management.